Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride use in young men with hair loss is linked to sexual dysfunction.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Finasteride can cause sexual problems and depression in young men.

The conclusion is that more research is needed to understand if the drug finasteride causes Post-Finasteride Syndrome or if it's due to individual genetic makeup.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

More people were diagnosed with certain skin diseases and sexually transmitted diseases in 2014 compared to 2003 in a Brazilian public institution.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Testosterone replacement therapy significantly improved sexual interest and function in HIV+ men.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.